Daniel L. Peters

Daniel L. Peters

Président chez
Phadia AB
74 ans
Health Technology
Commercial Services
Health Services

Profil

Daniel L.
Peters
is currently the Chairman at Phadia AB since 2008.
He was previously the President & CEO-Medical Diagnostics at GE Healthcare IVD Technologies from 2004 to 2007.
He was also the Director at MDRNA, Inc. from 2008 to 2010.
Peters served as the Director at various firms including Diatide, Inc., Pharmaceutical Research & Manufacturers of America, National Pharmaceutical Council, GE Healthcare AS, and Nycomed Amersham Imaging, Inc. He was the President, Chief Executive & Operating Officer at Molecular Insight Pharmaceuticals, Inc. from 2009 to 2010.
Peters was also the President-US Pharmaceutical Business at Sterling Winthrop, Inc. and the Chief Operating Officer at Amersham Health.
He served as a Trustee at HealthCare Institute of New Jersey from 1996 to 2006.
Peters completed his undergraduate degree from Western Illinois University.

Postes actifs de Daniel L. Peters

SociétésPosteDébut
Président 01/01/2008

Anciens postes connus de Daniel L. Peters

SociétésPosteFin
Directeur/Membre du Conseil 22/07/2010
ADHERA THERAPEUTICS, INC. Directeur/Membre du Conseil 21/07/2010
Corporate Officer/Principal 01/01/2007
Directeur/Membre du Conseil 01/01/2006
Directeur/Membre du Conseil 01/01/2005
Voir l'expérience en détail de Daniel L. Peters

Formation de Daniel L. Peters

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

56

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées14

Commercial Services

Health Services

Health Technology

Consumer Durables

Consumer Services

Process Industries

Amersham Health

Health Technology

Commercial Services

Health Technology

Distribution Services

Nycomed Amersham Imaging, Inc.

Health Technology

  1. Bourse
  2. Insiders
  3. Daniel L. Peters